原发性腹膜后肉瘤预后研究进展  

Research progress of prognosis for primary retroperitoneal sarcoma

作　　者：查立超 李修霞 周斌 田蓝天 曲腾飞[1] 邱法波[1] Cha Lichao;Li Xiuxia;Zhou Bin;Tian Lantian;Qu Tengfei;Qiu Fabo(Department of Retroperitoneal Tumors Surgery,Affiliated Hospital of Qingdao University,Shandong Qingdao 266003,China)

机构地区：[1]青岛大学附属医院腹膜后肿瘤外科,山东青岛266003

出　　处：《腹部外科》2020年第4期314-316,331,共4页Journal of Abdominal Surgery

基　　金：国家自然科学基金青年资助项目(81302077)。

摘　　要：原发性腹膜后肉瘤在临床上较为少见,然而病理类型繁多。手术切除是其主要的治疗方法,但术后的高复发率是此类疾病治疗的一大困扰。此文分析总结了相关文献,结果显示腹膜后肉瘤病人的预后主要与病理类型、肿瘤级别、手术范围及肿瘤数目等有关。Primary retroperitoneal sarcoma is rare in clinical practice,however there are many pathological types.Surgical resection is the main treatment,but the high recurrence rate after surgery is a major problem in the treatment of such diseases.The results showed that the prognosis of patients with retroperitoneal sarcoma was mainly related to pathological type,tumor grade,surgical range and tumor number.

关 键 词：腹膜后肿瘤 腹膜后肉瘤 脂肪肉瘤 预后 

分 类 号：R735.4[医药卫生—肿瘤]